145 related articles for article (PubMed ID: 26046133)
1. Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells.
Maniwa Y; Kasukabe T; Kumakura S
Int J Oncol; 2015 Aug; 47(2):473-80. PubMed ID: 26046133
[TBL] [Abstract][Full Text] [Related]
2. Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2.
Kasukabe T; Okabe-Kado J; Honma Y
Cancer Sci; 2008 Aug; 99(8):1693-8. PubMed ID: 18754885
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of leukemia cells with vitamin K2 and 1alpha,25-dihydroxy vitamin D3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1.
Iguchi T; Miyazawa K; Asada M; Gotoh A; Mizutani S; Ohyashiki K
Int J Oncol; 2005 Oct; 27(4):893-900. PubMed ID: 16142303
[TBL] [Abstract][Full Text] [Related]
4. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
[TBL] [Abstract][Full Text] [Related]
5. Korean red ginseng extract induces proliferation to differentiation transition of human acute promyelocytic leukemia cells via MYC-SKP2-CDKN1B axis.
Jo S; Lee H; Kim S; Lee CH; Chung H
J Ethnopharmacol; 2013 Nov; 150(2):700-7. PubMed ID: 24095829
[TBL] [Abstract][Full Text] [Related]
6. Cotylenin A and tyrosine kinase inhibitors synergistically inhibit the growth of chronic myeloid leukemia cells.
Ikejiri F; Honma Y; Okada T; Urano T; Suzumiya J
Int J Oncol; 2018 Jun; 52(6):2061-2068. PubMed ID: 29620253
[TBL] [Abstract][Full Text] [Related]
7. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
8. Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells.
Kasukabe T; Okabe-Kado J; Kato N; Honma Y; Kumakura S
Int J Oncol; 2015 Feb; 46(2):841-8. PubMed ID: 25405645
[TBL] [Abstract][Full Text] [Related]
9. Cotylenin A-induced differentiation is independent of the transforming growth factor-beta signaling system in human myeloid leukemia HL-60 cells.
Matsunawa M; Ishii Y; Kasukabe T; Tomoyasu S; Ota H; Honma Y
Leuk Lymphoma; 2006 Apr; 47(4):733-40. PubMed ID: 16690533
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts.
Kasukabe T; Okabe-Kado J; Kato N; Sassa T; Honma Y
Breast Cancer Res; 2005; 7(6):R1097-110. PubMed ID: 16457690
[TBL] [Abstract][Full Text] [Related]
11. Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A.
Horie A; Akimoto M; Tsumura H; Makishima M; Taketani T; Yamaguchi S; Honma Y
Leuk Res; 2008 Jul; 32(7):1112-23. PubMed ID: 18242698
[TBL] [Abstract][Full Text] [Related]
12. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
[No Abstract] [Full Text] [Related]
13. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
14. Induction of the monocytic differentiation of myeloid leukaemia cells by cotylenin A, a plant growth regulator.
Yamamoto-Yamaguchi Y; Yamada K; Ishii Y; Asahi KI; Tomoyasu S; Honma Y
Br J Haematol; 2001 Mar; 112(3):697-705. PubMed ID: 11260075
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
[TBL] [Abstract][Full Text] [Related]
16. Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemia.
Honma Y
Leuk Lymphoma; 2002 Jun; 43(6):1169-78. PubMed ID: 12152984
[TBL] [Abstract][Full Text] [Related]
17. The role of granulocyte-macrophage colony-stimulating factor in induction of monocytic differentiation of HL-60 cells: synergistic interaction with 1 alpha, 25-dihydroxyvitamin D3 and interferon-gamma in inducing interleukin-1 beta.
Nakamaki T; Kawakami K; Sato S; Hino K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
Anticancer Res; 1992; 12(5):1331-7. PubMed ID: 1444189
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells.
Miyazawa K; Yaguchi M; Funato K; Gotoh A; Kawanishi Y; Nishizawa Y; Yuo A; Ohyashiki K
Leukemia; 2001 Jul; 15(7):1111-7. PubMed ID: 11455981
[TBL] [Abstract][Full Text] [Related]
19. Axolotl
Suleiman S; Di Fiore R; Cassar A; Formosa MM; Schembri-Wismayer P; Calleja-Agius J
Tumour Biol; 2020 Sep; 42(9):1010428320954735. PubMed ID: 32873193
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest.
Jeong KC; Ahn KO; Yang CH
Mol Biosyst; 2010 Aug; 6(8):1503-9. PubMed ID: 20485733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
